Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

c-src structure in human cancers with elevated pp60c-src activity.

P Wang1, F Fromowitz, M Koslow

  • 1Department of Medicine, State University of New York, Stony Brook 11794.

British Journal of Cancer
|September 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Homeobox gene distal-less 3 is expressed in proliferating and differentiating cells of the human placenta.

Placenta·2010
Same author

Are functional deficits in concussed individuals consistent with white matter structural alterations: combined FMRI & DTI study.

Experimental brain research·2010
Same author

Postprandial lipaemia, oxidative stress and endothelial function: a review.

International journal of clinical practice·2010
Same author

Stability of crystalline sodium penicillin G.

The Pharmaceutical journal·2010
Same author

The problem of syphilis as seen by the Veterans Administration.

Journal of social hygiene·2010
Same author

Bacitracin therapy; Local treatment of the first 100 cases of antibiotic surgical infections.

Medizinische Nachrichten aus den Vereinigten Staaten·2010
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
Same journal

Planetary Health Diet Index and breast cancer risk.

British journal of cancer·2026
Same journal

Can national lung cancer screening programs be implemented without exacerbating social disparities?

British journal of cancer·2026
See all related articles

Activating mutations in the c-src gene are not responsible for increased kinase activity in human cancers. Researchers found no specific c-src mutations linked to cancer development, suggesting other mechanisms are at play.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The c-src proto-oncogene encodes a tyrosine kinase implicated in cell growth and differentiation.
  • Elevated pp60c-src kinase activity is observed in various human cancers, suggesting a role in tumorigenesis.
  • The precise mechanisms driving this enhanced kinase activity remain incompletely understood.

Purpose of the Study:

  • To investigate the role of activating mutations in the c-src gene in the development of human tumors.
  • To determine if specific mutations at key codons (98, 381, 444, 530) correlate with enhanced pp60c-src kinase activity in cancer.

Main Methods:

  • Utilized RNAase protection assays to detect specific RNA transcripts.
  • Employed restriction fragment length polymorphism (RFLP) assays to identify genetic variations.

Related Experiment Videos

  • Analyzed a spectrum of human tumor samples for c-src gene mutations.
  • Main Results:

    • No activating mutations were detected in the c-src gene at the targeted codons (98, 381, 444, and 530).
    • The absence of mutations suggests these specific sites are not responsible for c-src activation in the studied tumors.

    Conclusions:

    • Mutational activation of c-src at the examined codons is not the mechanism behind the enhanced pp60c-src kinase activity observed in human cancers.
    • Alternative molecular mechanisms likely contribute to the elevated kinase activity and oncogenic potential of c-src in tumorigenesis.